| 000 | 01749 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517185415.0 | ||
| 264 | 0 | _c20181126 | |
| 008 | 201811s 0 0 eng d | ||
| 022 | _a1521-4141 | ||
| 024 | 7 |
_a10.1002/eji.201747198 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBoff, Daiane | |
| 245 | 0 | 0 |
_aCXCR2 is critical for bacterial control and development of joint damage and pain in Staphylococcus aureus-induced septic arthritis in mouse. _h[electronic resource] |
| 260 |
_bEuropean journal of immunology _c03 2018 |
||
| 300 |
_a454-463 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aArthritis, Experimental _xetiology |
| 650 | 0 | 4 |
_aArthritis, Infectious _xetiology |
| 650 | 0 | 4 |
_aBacterial Load _xdrug effects |
| 650 | 0 | 4 |
_aJoints _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 |
_aNeutrophil Activation _xdrug effects |
| 650 | 0 | 4 |
_aPain _xdrug therapy |
| 650 | 0 | 4 |
_aReceptors, Interleukin-8A _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aReceptors, Interleukin-8B _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aStaphylococcal Infections _xcomplications |
| 650 | 0 | 4 |
_aStaphylococcus aureus _ximmunology |
| 650 | 0 | 4 |
_aSulfonamides _xpharmacology |
| 700 | 1 | _aOliveira, Vivian L S | |
| 700 | 1 | _aQueiroz Junior, Celso M | |
| 700 | 1 | _aSilva, Tarcília A | |
| 700 | 1 | _aAllegretti, Marcelo | |
| 700 | 1 | _aVerri, Waldiceu A | |
| 700 | 1 | _aProost, Paul | |
| 700 | 1 | _aTeixeira, Mauro M | |
| 700 | 1 | _aAmaral, Flavio A | |
| 773 | 0 |
_tEuropean journal of immunology _gvol. 48 _gno. 3 _gp. 454-463 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/eji.201747198 _zAvailable from publisher's website |
| 999 |
_c27818053 _d27818053 |
||